Auron Therapeutics, Inc.

Auron Therapeutics, Inc. company information, Employees & Contact Information

Auron Therapeutics is a privately held patient-centered, platform-powered, product-driven oncology company. We are the leaders in identifying and targeting cell state to treat a range of solid tumors and hematological malignancies.
Looking for a particular Auron Therapeutics, Inc. employee's phone or email?

Auron Therapeutics, Inc. Questions

News

Auron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial Officer - GlobeNewswire

Auron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial Officer GlobeNewswire

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia - Yahoo Finance

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia Yahoo Finance

AUTX-703 Receives FDA Fast Track Designation in Relapsed/Refractory AML - OncLive

AUTX-703 Receives FDA Fast Track Designation in Relapsed/Refractory AML OncLive

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit - GlobeNewswire

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit GlobeNewswire

Auron Therapeutics announces $48 million Series A financing to drive novel oncology pipeline leveraging a machine learning, multi-omics-based platform - Yahoo Finance

Auron Therapeutics announces $48 million Series A financing to drive novel oncology pipeline leveraging a machine learning, multi-omics-based platform Yahoo Finance

Auron Therapeutics Announces FDA Clearance to Initiate - GlobeNewswire

Auron Therapeutics Announces FDA Clearance to Initiate GlobeNewswire

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies - GlobeNewswire

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies GlobeNewswire

Top Auron Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant